A new injection mold should not move from a promising trial to a purchasing release on the strength of a few acceptable-looking parts. For an overseas OEM, the validation plan is the controlled agreement that connects the released product definition, tool build, trial purpose, evidence package, decision authority, and first-production safeguards. It gives procurement a common basis for comparing suppliers, quality a traceable route to approve or hold output, and engineering a way to distinguish learning from launch evidence.
The buyer should set the required evidence and acceptance decisions before the supplier starts the relevant run. The appropriate plan depends on the resin and its conditioning, part geometry, tool architecture and cavity arrangement, selected machine and auxiliaries, intended market, product risk, and contract or customer requirements. This guide does not prescribe a universal mold life, tolerance, cycle time, sample quantity, certification, or approval package. It identifies practical questions, records, and stage gates that a buyer can tailor to the program.
Requirement: no production release should be inferred from a trial sample alone. Recommendation: use named stage-gate approvers and a single controlled release record so that tool acceptance, part approval, and launch authorization cannot be confused.
01
1. Start with a launch-validation charter, not a generic trial request
Issue a controlled charter that identifies the part number, drawing and CAD revision, planned resin grade and approved alternatives, colour or additive direction where applicable, tool identifier, cavity strategy, target markets, intended annual demand range, and the decision the program must support. State whether the supplier is being asked to prove tool build completion, release samples for engineering evaluation, support a production-oriented submission, or prepare for routine supply. These are different decisions and may need different evidence. A supplier should acknowledge the baseline in writing and list any missing, conflicting, or assumed inputs before build or trial work proceeds.
Separate requirements from recommendations in the charter. Requirements come from the controlled design record, purchase order, quality agreement, applicable customer or regulatory obligations, and approved deviations. They may include named critical features, appearance references, material restrictions, packaging controls, traceability, report format, sample retention, or a customer-specific submission. Recommendations are buyer practices, such as a risk register or a meeting cadence, that help manage the launch but do not replace a contract requirement. Ask the supplier to mark each plan item as required, proposed, not applicable, or awaiting buyer decision.
Set an approval matrix before samples are made. Engineering normally owns design and functional acceptance, quality owns the adequacy of inspection and nonconformance disposition, procurement confirms the commercial and supplier-release conditions, and the program owner coordinates the gate. Titles differ by organization, so name actual roles and delegates. The first approval point is acceptance of the charter and evidence plan; it is not acceptance of the mold or molded parts.
02
2. Compare supplier readiness before authorising the decisive run
When comparing global suppliers, request the same readiness summary rather than accepting different slide decks. It should identify the controlled inputs received, DFM findings and unresolved design assumptions, proposed tool concept, cavity count and identification method, gating and runner approach, cooling and ejection considerations, proposed press and auxiliary equipment, resin preparation assumptions, intended measurement route, and the work needed before each gate. Ask what the supplier will do, what it will measure, and which decision each activity supports. A broad claim that a tool is “validated” is not comparable evidence.
Request a launch-risk log that links each material risk to an owner, mitigation, evidence due date, and approval point. Relevant risks can include a thin or cosmetic region, sealing or assembly interface, fiber orientation, shrinkage-sensitive dimension, multi-cavity variation, insert placement, post-molding operation, appearance standard, or export packaging. The log should also identify external dependencies, such as buyer-supplied gauges, mating components, resin approval, or customer review. A risk log does not prove the part will perform; it makes the assumptions and pending actions visible before schedule pressure turns them into undocumented exceptions.
For the tool itself, ask for controlled build evidence appropriate to the contract: tool identification, major component and insert status, cavity numbering where relevant, revision status, preventive-maintenance proposal, spare-parts proposal if contracted, and a record of changes made after trials. Do not assume that a particular steel grade, hot-runner brand, tooling warranty, or maintenance interval is suitable for every program. Those choices depend on resin, geometry, operating conditions, tool architecture, production plan, and the parties’ agreement.
03
3. Use stage gates to keep exploratory trials separate from launch evidence
A useful plan labels the purpose and limits of every run. An early fill, ejection, or cosmetic trial can reveal where the tool or process needs work, but it should not silently become the basis for a production release. Conversely, a production-oriented run should have a declared tool state, controlled material preparation, identified machine and auxiliaries, defined inspection scope, and traceable samples. If any condition differs from the agreed baseline, the supplier should disclose it and the buyer should decide whether the evidence remains fit for the stated decision.
The following gate table is a planning model, not a universal qualification sequence. A medical, automotive, consumer, industrial, or contract-specific program may require a different submission, named terminology, or additional approvals. The buyer should state those requirements rather than assume that labels such as T1, FAI, PPAP, IQ, OQ, or PQ mean the same thing for every supplier.
| Gate | Buyer should define or request | Supplier evidence | Approval or hold point |
|---|---|---|---|
| Plan freeze | Released input index, critical requirements, acceptance methods, evidence list, approvers and change route | Feasibility response, assumptions, risk log and dated validation schedule | Buyer accepts the plan or returns gaps; no implied tool or part approval |
| Tool-build readiness | Tool specification, identification convention and pre-trial criteria required by the agreement | Controlled tool-build status, open-item list and proposed trial conditions | Authorize a defined trial only when critical build gaps are understood |
| Engineering trial | Purpose of the run and the questions it must answer, including any safety or functional limits | Run record, identified samples, tool/process observations, measurement and action proposal | Decide tool correction, further study, or readiness for a production-oriented run |
| Launch-evidence run | Declared baseline, inspection and functional scope, lot and cavity traceability, and required submission format | Material and preparation record, process record, dimensional/visual/functional results, nonconformance disposition and control proposal | Approve, conditionally approve, or hold the part and process baseline in writing |
| First production release | Containment, shipment release, packaging verification, escalation contacts and change-notification triggers | First-lot traceability and agreed release records; status of any approved open actions | Authorize routine supply only within the written release conditions |
04
4. Ask for evidence that connects the part, tool, process and measurement decision
A buyer-ready package should allow a reviewer to answer four questions without reconstructing the story from emails: what was made, against which controlled requirements, under what identified conditions, and what decision follows. Request sample and lot identification; drawing, CAD, tool, and process revision; tool and cavity identity when practical; resin grade, supplier/lot, and material-preparation record; press and relevant auxiliary identification; run date; and the declared inspection and functional-test methods. For a multi-cavity tool, pooled values can mask a cavity-specific condition, so request cavity-linked evidence where the risk and tooling arrangement make it relevant.
For each critical-to-quality feature or critical interface, define the requirement source, datum or reference, inspection method and fixture, units, conditioning or timing, sampling rationale, acceptance rule, and reporting format. Ask the supplier to identify features that were not measured and why. Dimensional results are only as useful as the method that produced them. The supplier should provide suitable measurement-system and calibration or traceability information when the contract, product risk, or customer requirement calls for it. Calibration alone is not proof that a measurement result is fit for purpose; the method, uncertainty, fixturing, and feature risk still matter.
Request evidence proportionate to the release question. It can include material documentation required by the program, dimensional and appearance reports, functional or assembly results, tool-change history, process-control instructions, packaging verification, and a nonconformance or deviation record. PPAP may be the agreed framework in some automotive supply chains, but it should be requested only where the customer, contract, or program calls for it. In other programs, define an equivalent, decision-focused evidence index instead of asking a supplier to guess which PPAP elements are wanted.
05
5. Approve with conditions, then control the launch baseline
The release record should state exactly what is approved: the part and drawing revision, material basis, tool and cavity configuration, evidence run or lot, scope of acceptance, and effective date. It should distinguish approval of the tool from approval of the molded part and from authorization to ship production. If the buyer accepts a deviation, record the affected condition, quantity or time limit, disposition authority, follow-up action, and whether another review is required. A conditional release is a controlled exception, not a reason to leave a requirement unresolved.
Before first production, agree a short launch-control plan. Define the first-lot or early-production containment that is actually required, shipment-release evidence, incoming or receiving checks if any, escalation contacts across time zones, response timing agreed by contract, and the route for correcting a suspected issue. The plan should include a list of change triggers: drawing or CAD revision, resin grade or formulation change, colour/additive change, tool modification or major repair, cavity addition, process-route or machine change, measurement-method change, and a packaging change that could affect the product. The buyer and supplier should decide case by case what notification, evaluation, re-sampling, or reapproval each trigger needs.
Close the launch gate only when the named approvers have accepted the evidence or recorded the remaining conditions. Retain the charter, evidence index, supplier records, meeting decisions, and release record together in controlled storage. This creates a usable baseline for supplier management and later changes. It does not guarantee field performance, regulatory acceptance, or future output; those outcomes remain dependent on the part, application, material, tooling, process control, market obligations, and contract terms.
Practical takeaway
Before you move
to the next review.
- Freeze the controlled part definition, resin direction, target markets, tool identity and launch decision before requesting the supplier’s validation plan.
- Require a supplier readiness summary and risk log that state assumptions, open inputs, tool and process dependencies, evidence due dates, owners and gate decisions.
- Label every trial by purpose and prevent exploratory samples from being treated as production-release evidence without a written buyer decision.
- Request traceable evidence linking samples to the part, tool/cavity where relevant, material preparation, machine conditions, inspection method, functional checks and nonconformance disposition.
- Issue one controlled tool, part and shipment-release record with approvers, deviations, open actions, first-lot controls and change/reapproval triggers.
FAQ
Common questions
What is the difference between injection mold acceptance and new-product launch approval?
Mold acceptance concerns the tool deliverable and the contractually agreed evidence that it is in an acceptable state for its intended use. Launch approval is a buyer decision to use identified molded output for a defined supply purpose. It normally considers the controlled part definition, material, evidence run, inspection and functional results, packaging, and any open conditions. One decision should not be assumed to grant the other; the contract and validation charter should state the relationship.
How should a buyer compare two suppliers if both provide acceptable trial samples?
Compare the evidence behind the samples, not only the parts. Check whether each supplier used the same released revision, material direction, acceptance methods, sample identification, tool configuration, and declared trial purpose. Compare unresolved DFM or risk-log items, measurement coverage and method, tool-change history, traceability, control proposal, and the clarity of the proposed release conditions. An attractive sample made under an unclear baseline is weaker launch evidence than a fully traceable result.
Should every program require PPAP or IQ/OQ/PQ documents?
No. PPAP is commonly used where an automotive customer or contract specifies it, while IQ/OQ/PQ terminology is often used in regulated validation systems. Neither label automatically defines the right evidence for every molded part. State the customer, market, contract, and product-specific requirements, then request a proportionate package that supports the actual approval decision. Where a named framework is mandatory, define the edition, submission level or protocol expectations, and responsible approvers.
When should a buyer request another validation review after launch?
Request a documented impact review when a proposed change could affect the approved baseline or a critical requirement. Common triggers include a drawing or resin change, significant tool repair or modification, cavity change, process-route or machine change, revised inspection method, recurring nonconformance, or packaging change that could affect part condition. The needed response may range from notification to targeted samples or a new approval run; it depends on the risk, evidence available, destination-market obligations, and the contract.
References
Source material
- [1] AIAG, Production Part Approval Process (PPAP)
- [2] U.S. Food and Drug Administration, Process Validation: General Principles and Practices
- [3] National Institute of Standards and Technology, Metrological Traceability
- [4] International Organization for Standardization, ISO 9001:2026 Quality management systems — Requirements
This guide is general information for early procurement and engineering discussion. It does not replace product-specific DFM, qualification, validation, regulatory assessment or legal advice.